Key result
CMR-derived global wall thickness tracks post-intervention LV remodeling without confounding by end-diastolic volume.
Why the study?
Cardiovascular interventions may impact both left ventricular mass and end-diastolic volume, making the net effect on wall thickness difficult to accurately evaluate. Whether global average left ventricular end-diastolic wall thickness can serve as an ideal measure of post-intervention change in left ventricular hypertrophy required evaluation.
Does global average left ventricular end-diastolic wall thickness (GT) by cardiovascular magnetic resonance more accurately and consistently detect post-intervention cardiac remodelling in left ventricular hypertrophy compared to the left ventricular mass-to-volume ratio (LVM/EDV)?
Cohort (n=4,727)
Yes
Does global average left ventricular end-diastolic wall thickness (GT) by cardiovascular magnetic resonance more accurately and consistently detect post-intervention cardiac remodelling in left ventricular hypertrophy compared to the left ventricular mass-to-volume ratio (LVM/EDV)?
Answers are grounded in this paper and cite their sources.
Global average left ventricular end-diastolic wall thickness (GT) measured by CMR is independent of ventricular volume in health and outperforms the traditional mass-to-volume ratio (LVM/EDV) in detecting and differentiating left ventricular remodelling across diverse clinical interventions.
Background: Cardiovascular interventions may impact both left ventricular mass (LVM) and end-diastolic volume (EDV), but the net effect on wall thickness has been difficult to accurately evaluate. Global average left ventricular end-diastolic wall thickness (GT) relates non-linearly to LVM and EDV. We hypothesized that if GT is independent of EDV in health, then GT will be an ideal measure of post-intervention change in left ventricular hypertrophy. Methods: GT [mm] was calculated using LVM and EDV by cardiovascular magnetic resonance as previously validated. The correlation between GT and EDV was evaluated in healthy volunteers. Change in GT following intervention was evaluated for aortic stenosis undergoing valve replacement, hypertension commencing antihypertensive medications, athletes undergoing forced detraining, and aortic regurgitation undergoing valve replacement. The performance of GT was compared to LVM/EDV. Results: Among healthy volunteers (n=4461, mean+/-SD age 59+/-10 years, 50% female), EDV correlated with LVM/EDV but negligibly with GT (R2>0.16 vs R2<0.02, p<0.001 for both sexes). GT and not LVM/EDV changed after intervention in all conditions (p≤0.02 for all). Post-intervention changes in GT varied by condition (mean+/-SEM aortic stenosis [n=102]: -1.75+/-0.13mm, hypertension [n=78]: -0.66+/-0.08mm, athletes [n=28]: -0.29+/-0.09mm, aortic regurgitation [n=58]: +0.50+/-0.11 mm, p≤0.02 for all comparisons). Conclusions: In health, GT, unlike LVM/EDV, remains effectively unchanged across EDV values, indicating that GT is a physiological constant in health and can track pathological changes. After intervention, only GT and not LVM/EDV consistently changed. Instead of LVM/EDV, GT should be used to quantify remodelling after interventions in left ventricular hypertrophy.
No takes yet. Share an insight, caveat, or question.
Khor et al. (2026) conducted a cohort in Left ventricular hypertrophy across aortic stenosis, hypertension, athletic remodeling, and aortic regurgitation alongside healthy volunteers (n=4,727). Global average left ventricular end-diastolic wall thickness (GT) assessment by CMR vs. Left ventricular mass-to-end-diastolic volume ratio (LVM/EDV) was evaluated on Post-intervention change in global average left ventricular end-diastolic wall thickness (GT) and correlation with EDV in health (R2<0.02 vs R2>0.16 in health; GT changed in all 4 intervention cohorts (AS -1.75 mm, HTN -0.66 mm, athletes -0.29 mm, AR +0.50 mm), p=≤0.02). Global wall thickness (GT) by CMR had negligible correlation with EDV in health (R2<0.02, p<0.001) and consistently detected post-intervention LVH remodeling across all 4 cohorts (p≤0.02).
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: